Olpress 3D Tablet
Images are for reference. Actual packaging may vary.
Olmesartan Medoxomil (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Strip of 15 tablets • Tablet
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+2 more active ingredients
Olmesartan Medoxomil blocks angiotensin II receptors, preventing vasoconstriction and lowering blood pressure.
Hydrochlorothiazide inhibits sodium reabsorption in the distal convoluted tubule, leading to increased urine output and decreased blood volume.
Amlodipine inhibits calcium ion influx into vascular smooth muscle and cardiac muscle, leading to vasodilation and reduced myocardial oxygen demand.
Medical applications
Olpress 3D Tablet is a combination antihypertensive medication containing Olmesartan Medoxomil 40 mg, Amlodipine 5 mg, and Hydrochlorothiazide 12.5 mg. This formulation is designed to manage hypertension by targeting multiple physiological pathways to achieve optimal blood pressure control. Olmesartan Medoxomil, an angiotensin II receptor antagonist, inhibits vasoconstriction and aldosterone secretion, thereby reducing peripheral resistance.
Amlodipine, a calcium channel blocker, promotes vasodilation by inhibiting calcium ion influx into vascular smooth muscle cells, further lowering blood pressure. Hydrochlorothiazide, a thiazide diuretic, enhances sodium and water excretion, decreasing blood volume and systemic vascular resistance. The synergistic effect of these agents provides effective blood pressure reduction in patients inadequately controlled by monotherapy or dual therapy.
Olpress 3D is indicated for essential hypertension and may reduce the risk of cardiovascular events associated with high blood pressure. It is contraindicated in patients with hypersensitivity to any component, anuria, or severe renal impairment. Caution is advised in patients with electrolyte imbalances or gout. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy.
Olpress 3D should be used under medical supervision with adherence to prescribed dosing to ensure safety and efficacy.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Olpress 3D Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Olpress 3D Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Olpress 3D Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Olpress 3D Tablet may be needed. Please consult your doctor. Use of Olpress 3D Tablet is not recommended in patients with severe kidney disease.
Exercise Caution
Olpress 3D Tablet may cause side effects which could affect your ability to drive. Olpress 3D Tablet may cause side effects such as dizziness, headaches, nausea or tiredness, all of which could affect your ability to concentrate and drive.
Consult Doctor
Olpress 3D Tablet should be used with caution in patients with liver disease. Dose adjustment of Olpress 3D Tablet may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Olpress 3D Tablet






